As shown in Figure 2a–d, patients with high expression of STOX1 had significantly longer OS than those with low STOX1 expression in all gliomas or GBM cohort alone in both CGGA (All gliomas, P < 0.001 and GBM, P = 0.007) and TCGA (All gliomas, P < 0.001 and GBM, P = 0.018) datasets. This evidence concerns the gene STOX1 and glioblastoma.